Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Current Deferred Revenue (2016 - 2018)

InflaRx's Current Deferred Revenue history spans 3 years, with the latest figure at $13957.6 for Q3 2018.

  • On a quarterly basis, Current Deferred Revenue fell 25.76% to $13957.6 in Q3 2018 year-over-year; TTM through Sep 2018 was $13957.6, a 25.76% decrease, with the full-year FY2017 number at $17661.5, down 16.03% from a year prior.
  • Current Deferred Revenue hit $13957.6 in Q3 2018 for InflaRx, down from $15514.8 in the prior quarter.
  • Over the last five years, Current Deferred Revenue for IFRX hit a ceiling of $20514.8 in Q4 2016 and a floor of $13957.6 in Q3 2018.
  • Historically, Current Deferred Revenue has averaged $17274.8 across 3 years, with a median of $17430.5 in 2018.
  • Biggest five-year swings in Current Deferred Revenue: dropped 13.91% in 2017 and later decreased 25.76% in 2018.
  • Tracing IFRX's Current Deferred Revenue over 3 years: stood at $20514.8 in 2016, then fell by 13.91% to $17661.5 in 2017, then decreased by 20.97% to $13957.6 in 2018.
  • Business Quant data shows Current Deferred Revenue for IFRX at $13957.6 in Q3 2018, $15514.8 in Q2 2018, and $17199.5 in Q1 2018.